Research
HIV drug lenacapavir found to disrupt virus formation, creating giant noninfectious particles
The Brief
- Researchers found that the HIV drug lenacapavir also disrupts the formation of new virus particles.
- Lenacapavir was already known to block key steps in HIV replication after the virus enters a cell.
- The disruption produces giant particles that are noninfectious.
Why it matters
The finding adds a second mechanism to how lenacapavir suppresses HIV, which could inform understanding of the drug's action and future antiviral design.
Who’s affected
- HIV researchers and clinicians
- people involved in HIV prevention and treatment
- #hiv
- #lenacapavir
- #antiviral drugs
- #virus assembly
- #hiv prevention
Lenacapavir is a powerful, long-acting drug used to prevent and treat HIV infection. While it is known to block key steps in the virus's replication after entering a cell, researchers have now uncovered another way the drug works: it disrupts the formation of new virus particles…